Lupin Pharmaceuticals, Inc. announced today that it has received final approval for the Company's Abbreviated New Drug Application for Levetiracetam Tablets 250mg, 500mg, 750mg and 1000mg from the U.S. FDA. Commercial shipments of the product have commenced.
the details can be read here.
No comments:
Post a Comment